---
title: "BTMD.US (BTMD.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BTMD.US/news.md"
symbol: "BTMD.US"
name: "BTMD.US"
parent: "https://longbridge.com/en/quote/BTMD.US.md"
datetime: "2026-05-20T15:54:51.307Z"
locales:
  - [en](https://longbridge.com/en/quote/BTMD.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BTMD.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BTMD.US/news.md)
---

# BTMD.US (BTMD.US) — Related News

### [biote shareholders elect directors and ratify Deloitte appointment](https://longbridge.com/en/news/286825538.md)
*2026-05-18T22:29:19.000Z*
> Biote Corp. held its 2026 annual meeting, where shareholders elected Andrew R. Heyer and Dana Jacoby as Class I director

### [biote Corp. | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 44.94 M](https://longbridge.com/en/news/285477121.md)
*2026-05-07T03:11:58.000Z*
### [biote Corp. | 10-K: FY2025 Revenue Beats Estimate at USD 192.22 M](https://longbridge.com/en/news/283962018.md)
*2026-04-24T08:38:13.000Z*
### [biote (NASDAQ:BTMD) Trading Down 0.9%  - What's Next?](https://longbridge.com/en/news/283935772.md)
*2026-04-24T04:58:23.000Z*
> biote Corp. (NASDAQ:BTMD) shares fell 0.9% to $2.22 during mid-day trading, with a volume decline of 52% from the averag

### [NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization | NRXBF Stock News](https://longbridge.com/en/news/281889726.md)
*2026-04-07T05:20:29.000Z*
> NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and C

### [Biote posts April 2026 investor presentation highlighting $192.2M 2025 revenue and $53.5M Adj. EBITDA](https://longbridge.com/en/news/281660267.md)
*2026-04-03T20:13:01.000Z*
> Biote's April 2026 investor presentation revealed 2025 revenue of $192.2M and adjusted EBITDA of $53.5M, with a 27.8% ma

### [MindBio Announces Closing of Private Placement](https://longbridge.com/en/news/281416173.md)
*2026-04-01T19:45:03.000Z*
> MindBio Therapeutics Corp. has successfully closed a private placement, raising $1,437,828.87 by issuing 2,396,381 units

### [MindBio Announces Upsize to Private Placement up to $1.5 Million](https://longbridge.com/en/news/279783584.md)
*2026-03-19T12:05:59.000Z*
> MindBio Therapeutics Corp. has announced an increase in its non-brokered private placement from $650,000 to up to $1.5 m